Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2.

Genes, chromosomes & cancer - 1 May 2003

Snaddon Jennifer, Smith Matthew L, Neat Michael, Cambal-Parrales Maxine, Dixon-McIver Amanda, Arch Rachael, Amess John A, Rohatiner Ama Z, Lister T Andrew, Fitzgibbon Jude

Abstract excerpt

CEBPA encodes the transcription factor C/EBPalpha and is specifically up-regulated during granulocytic differentiation. The gene is mutated in approximately 20% of patients with acute myeloid leukemia (AML) FAB type M2 and occurs in the absence of the t(8;21). In much the same way as specific tra...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Amino Acid Sequence
Share to CCAAT-Enhancer-Binding Protein-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to DNA, Neoplasm

Share to Leucine Zippers

Share to Leukemia, Myeloid, Acute

Share to Risk Factors

Source

Identifiers

PMID: 12661007
DOI: 10.1002/gcc.10185

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12661007-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2.PMID 12661007Read ↗

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA).Semantic proximity Read ↗

Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML.Semantic proximity Read ↗

Infrequent hypermethylation of <i>CEBPA</i> promotor in acute myeloid leukaemiaSemantic proximity Read ↗

Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical OutcomeSemantic proximity Read ↗

Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.Semantic proximity Read ↗

Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells.Semantic proximity Read ↗

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.Semantic proximity Read ↗

Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias.Semantic proximity Read ↗

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupSemantic proximity Read ↗

Mutations in the bZip region of the CEBPA gene: A novel prognostic factor in patients with acute myeloid leukemia.Semantic proximity Read ↗

Mutation of CEBPA in familial acute myeloid leukemia.Semantic proximity Read ↗

CEBPalpha mutations in childhood acute myeloid leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.